Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AMN Stock Summary
Top 10 Correlated ETFs
AMN
In the News
AMN Financial details
Company Rating
Strong Buy
Market Cap
2.15B
Income
210.68M
Revenue
3.79B
Book val./share
21.84
Cash/share
2.67
Dividend
-
Dividend %
-
Employees
3.59K
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
10.48
Forward P/E
-
PEG
-2.24
P/S
0.58
P/B
2.65
P/C
21.25
P/FCF
8.23
Quick Ratio
1.28
Current Ratio
1.28
Debt / Equity
1.58
LT Debt / Equity
1.57
-
-
EPS (TTM)
5.31
EPS next Y
-
EPS next Q
-
EPS this Y
-45.98%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
17.13%
Revenue last 5Y
11.26%
Revenue Q/Q
-4.12%
EPS Q/Q
-76.26%
-
-
-
-
SMA20
-9.52%
SMA50
-24%
SMA100
-14.93%
Inst Own
82.77%
Inst Trans
0.86%
ROA
7%
ROE
25%
ROC
0.15%
Gross Margin
32%
Oper. Margin
9%
Profit Margin
6%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
53.77-112.44
52W High
-49.34%
52W Low
+7.06%
RSI
40
Rel Volume
0.31
Avg Volume
820.88K
Volume
251.92K
Perf Week
-0.73%
Perf Month
-6.82%
Perf Quarter
-25.05%
Perf Half Y
-23.17%
-
-
-
-
Beta
0.212
-
-
Volatility
0.28%, 3%
Prev Close
0.78%
Price
56.74
Change
0.76%
AMN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 47.58 | 50.47 | 83.55 | 117.59 | 96.73 | |
Net income per share | 2.44 | 1.49 | 6.87 | 9.96 | 5.38 | |
Operating cash flow per share | 4.81 | 5.42 | 6.4 | 14.66 | 9.5 | |
Free cash flow per share | 4.03 | 4.59 | 5.28 | 12.85 | 6.81 | |
Cash per share | 3.11 | 1.91 | 5.15 | 2.82 | 2.6 | |
Book value per share | 15.77 | 17.28 | 24.37 | 23.4 | 21.22 | |
Tangible book value per share | -5.51 | -12.86 | -5.13 | -8.27 | -19.26 | |
Share holders equity per share | 15.77 | 17.28 | 24.37 | 23.4 | 21.22 | |
Interest debt per share | 16.07 | 21.37 | 18.9 | 20.21 | 34.72 | |
Market cap | 2.91B | 3.24B | 5.83B | 4.58B | 2.93B | |
Enterprise value | 3.55B | 4.16B | 6.52B | 5.38B | 4.21B | |
P/E ratio | 25.53 | 45.8 | 17.82 | 10.33 | 13.92 | |
Price to sales ratio | 1.31 | 1.35 | 1.46 | 0.87 | 0.77 | |
POCF ratio | 12.94 | 12.6 | 19.1 | 7.01 | 7.88 | |
PFCF ratio | 15.45 | 14.87 | 23.18 | 8 | 11 | |
P/B Ratio | 3.95 | 3.95 | 5.02 | 4.39 | 3.53 | |
PTB ratio | 3.95 | 3.95 | 5.02 | 4.39 | 3.53 | |
EV to sales | 1.6 | 1.74 | 1.64 | 1.03 | 1.11 | |
Enterprise value over EBITDA | 15.08 | 17.2 | 11.26 | 6.9 | 8.42 | |
EV to operating cash flow | 15.79 | 16.21 | 21.35 | 8.23 | 11.3 | |
EV to free cash flow | 18.84 | 19.12 | 25.9 | 9.39 | 15.76 | |
Earnings yield | 0.04 | 0.02 | 0.06 | 0.1 | 0.07 | |
Free cash flow yield | 0.06 | 0.07 | 0.04 | 0.12 | 0.09 | |
Debt to equity | 0.98 | 1.17 | 0.75 | 0.82 | 1.58 | |
Debt to assets | 0.37 | 0.41 | 0.28 | 0.3 | 0.45 | |
Net debt to EBITDA | 2.72 | 3.83 | 1.18 | 1.02 | 2.55 | |
Current ratio | 1.48 | 1.26 | 1.39 | 1.27 | 1.28 | |
Interest coverage | 6.22 | 2.59 | 14.03 | 16.02 | 7.13 | |
Income quality | 1.97 | 3.63 | 0.93 | 1.47 | 1.77 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.23 | 0.23 | 0.18 | 0.18 | 0.2 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.51 | 0.61 | 0.45 | 0.49 | 0.54 | |
Capex to operating cash flow | -0.16 | -0.15 | -0.18 | -0.12 | -0.28 | |
Capex to revenue | -0.02 | -0.02 | -0.01 | -0.02 | -0.03 | |
Capex to depreciation | -0.62 | -0.42 | -0.52 | -0.59 | -0.65 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 29.43 | 24.07 | 61.35 | 72.42 | 50.67 | |
ROIC | 0.09 | 0.06 | 0.17 | 0.25 | 0.11 | |
Return on tangible assets | 0.12 | 0.08 | 0.19 | 0.3 | 0.16 | |
Graham Net | -15.26 | -22.91 | -18.92 | -22.67 | -36.64 | |
Working capital | 182.39M | 110.78M | 379.68M | 235.71M | 185.56M | |
Tangible asset value | -257.28M | -609.72M | -244.77M | -368.56M | -754.43M | |
Net current asset value | -634.41M | -1B | -620.81M | -751.07M | -1.25B | |
Invested capital | 0.98 | 1.17 | 0.75 | 0.82 | 1.58 | |
Average receivables | 420.71M | 437.74M | 739.47M | 986.61M | 842.78M | |
Average payables | 92.49M | 105M | 223.23M | 356.17M | 358.58M | |
Average inventory | 37.79M | 37.45M | 70.28M | 50.86M | 0 | |
Days sales outstanding | 69.88 | 68.63 | 94.25 | 65.74 | 71.4 | |
Days payables outstanding | 25.31 | 24.48 | 46.26 | 38.64 | 46.58 | |
Days of inventory on hand | 8.9 | 8.85 | 13.88 | 0 | 0 | |
Receivables turnover | 5.22 | 5.32 | 3.87 | 5.55 | 5.11 | |
Payables turnover | 14.42 | 14.91 | 7.89 | 9.45 | 7.84 | |
Inventory turnover | 41.02 | 41.24 | 26.29 | 0 | 0 | |
ROE | 0.15 | 0.09 | 0.28 | 0.43 | 0.25 | |
Capex per share | -0.78 | -0.82 | -1.13 | -1.81 | -2.69 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 26.05 | 27.22 | 25.32 | 22.37 | 21.5 | |
Net income per share | 1.89 | 2.03 | 1.56 | 1.39 | 0.33 | |
Operating cash flow per share | 2.67 | 1.05 | 5.05 | 4.51 | -1.08 | |
Free cash flow per share | 2.1 | 0.63 | 4.37 | 3.73 | -1.91 | |
Cash per share | 2.91 | 2.32 | 2.01 | 2.6 | 2.67 | |
Book value per share | 24.15 | 23.1 | 19.57 | 21.42 | 21.84 | |
Tangible book value per share | -8.53 | -10.49 | -15.37 | -13.85 | -19.82 | |
Share holders equity per share | 24.15 | 23.1 | 19.57 | 21.42 | 21.84 | |
Interest debt per share | 20.2 | 24.21 | 26.94 | 25.15 | 34.84 | |
Market cap | 4.44B | 3.43B | 4.27B | 3.25B | 2.85B | |
Enterprise value | 5.24B | 4.39B | 5.3B | 4.16B | 4.12B | |
P/E ratio | 13.58 | 10.2 | 17.54 | 15.28 | 57.05 | |
Price to sales ratio | 3.95 | 3.05 | 4.31 | 3.81 | 3.48 | |
POCF ratio | 38.52 | 79.03 | 21.61 | 18.87 | -69.3 | |
PFCF ratio | 48.97 | 132.3 | 24.95 | 22.83 | -39.21 | |
P/B Ratio | 4.26 | 3.59 | 5.58 | 3.98 | 3.43 | |
PTB ratio | 4.26 | 3.59 | 5.58 | 3.98 | 3.43 | |
EV to sales | 4.66 | 3.9 | 5.35 | 4.87 | 5.04 | |
Enterprise value over EBITDA | 33.56 | 26.88 | 41.24 | 32.98 | 53.32 | |
EV to operating cash flow | 45.43 | 101.03 | 26.81 | 24.16 | -100.22 | |
EV to free cash flow | 57.75 | 169.11 | 30.95 | 29.23 | -56.71 | |
Earnings yield | 0.02 | 0.02 | 0.01 | 0.02 | 0 | |
Free cash flow yield | 0.02 | 0.01 | 0.04 | 0.04 | -0.03 | |
Debt to equity | 0.82 | 1.04 | 1.36 | 1.16 | 1.58 | |
Debt to assets | 0.3 | 0.34 | 0.39 | 0.36 | 0.45 | |
Net debt to EBITDA | 5.1 | 5.85 | 7.99 | 7.22 | 16.45 | |
Current ratio | 1.27 | 1.33 | 1.2 | 1.18 | 1.28 | |
Interest coverage | 10.13 | 12.25 | 7.53 | 7.53 | 2.54 | |
Income quality | 1.41 | 0.52 | 3.25 | 3.24 | -3.29 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.19 | 0.18 | 0.2 | 0.19 | 0.7 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.49 | 0.48 | 0.52 | 0.51 | 0.54 | |
Capex to operating cash flow | -0.21 | -0.4 | -0.13 | -0.17 | 0.77 | |
Capex to revenue | -0.02 | -0.02 | -0.03 | -0.04 | -0.04 | |
Capex to depreciation | -0.65 | -0.45 | -0.69 | -0.76 | -0.73 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Graham number | 32.07 | 32.5 | 26.17 | 25.92 | 12.7 | |
ROIC | 0.05 | 0.05 | 0.04 | 0.03 | 0.01 | |
Return on tangible assets | 0.06 | 0.06 | 0.05 | 0.04 | 0.01 | |
Graham Net | -23.39 | -26.02 | -31.63 | -30.98 | -37.71 | |
Working capital | 235.71M | 267.46M | 133.52M | 123.99M | 185.56M | |
Tangible asset value | -368.56M | -434.03M | -601.85M | -528.41M | -754.43M | |
Net current asset value | -751.07M | -854.23M | -1.07B | -1.01B | -1.25B | |
Invested capital | 0.82 | 1.04 | 1.36 | 1.16 | 1.58 | |
Average receivables | 962.36M | 954.34M | 856.23M | 744.93M | 741.45M | |
Average payables | 356.17M | 366.6M | 291.25M | 235.56M | 296.18M | |
Average inventory | 22.39M | 29.1M | 29.1M | 0.5 | 0 | |
Days sales outstanding | 75.52 | 77.06 | 67.93 | 78.21 | 81.52 | |
Days payables outstanding | 44.78 | 42.76 | 30.31 | 39.66 | 51.69 | |
Days of inventory on hand | 0 | 6.92 | 0 | 0 | 0 | |
Receivables turnover | 1.19 | 1.17 | 1.32 | 1.15 | 1.1 | |
Payables turnover | 2.01 | 2.1 | 2.97 | 2.27 | 1.74 | |
Inventory turnover | 0 | 13.01 | 661.02M | 0 | 0 | |
ROE | 0.08 | 0.09 | 0.08 | 0.07 | 0.02 | |
Capex per share | -0.57 | -0.42 | -0.68 | -0.78 | -0.83 |
AMN Frequently Asked Questions
What is AMN Healthcare Services, Inc. stock symbol ?
AMN Healthcare Services, Inc. is a US stock , located in Dallas of Tx and trading under the symbol AMN
What is AMN Healthcare Services, Inc. stock quote today ?
AMN Healthcare Services, Inc. stock price is $56.74 today.
Is AMN Healthcare Services, Inc. stock public?
Yes, AMN Healthcare Services, Inc. is a publicly traded company.